CEBEMIRA-S 25/5 TABLETS
CEBEMIRA-S 25/5 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | CEBEMIRA-S 25/5 Tablets |
| Form | Tablets |
| Key Ingredients | Telmisartan 25 mg + Cilnidipine 5 mg |
| Core Benefits | Controls blood pressure, protects heart and kidneys |
| Mechanism of Action | ARB + Calcium Channel Blocker: relaxes blood vessels, reduces resistance |
| Support Areas | Hypertension, cardiovascular protection, renal safety |
| Recommended Usage | 1 tablet once daily or as prescribed by a physician |
| Target Audience | Adults with mild-to-moderate hypertension |
Composition: Mirabegron 25mg Extended Release + Solifenacin 5mg Packing: 10×10 Alu-Alu
Description : CEBEMIRA-S 25/5 Tablets combine Cilnidipine 5 mg and Telmisartan 25 mg, offering a dual-action treatment for hypertension (high blood pressure). Telmisartan, an angiotensin II receptor blocker (ARB), lowers blood pressure by relaxing blood vessels, while Cilnidipine, a calcium channel blocker, also controls BP and protects against cardiovascular damage. This combination helps reduce the risk of heart attacks, strokes, and kidney complications in hypertensive patients. CEBEMIRA-S 25/5 ensures effective and sustained blood pressure control with once-daily dosing under medical supervision.